Promising pathway for predictive biomarkers in lung cancer immunotherapy revealed

Both low-risk and high-risk obstetric patients at low-volume hospitals in rural counties had higher risk for severe maternal morbidity (SMM) compared with rural hospitals delivering

Chugai, a Japan­ese phar­ma owned by Roche, is part­ner­ing with a small Swiss biotech to work on next-gen­er­a­tion an­ti­body-drug con­ju­gates that de­liv­er mul­ti­ple cy­to­tox­ic mol­e­cules

Fewer than one in five people eligible for lung cancer screening reported being up to date with screening in 2022, though patient navigation added to